Steven Renwick, PhD (Advisor, PharmaVentures)




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Steven Renwick, PhD (Advisor, PharmaVentures)
Released on: February 26, 2010. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    A PharmaTelevision News story featuring analysis from PharmaVentures' Steven Renwick.
  • Summary
  • Company
A PharmaTelevision News story featuring analysis from PharmaVentures' Steven Renwick.

Steven is a transactions specialist with experience in asset divestments and IP screening and sourcing, as well as competitive analysis and licensing litigation cases wherein PharmaVentures served as expert witness. He also conducts research on industry licensing practices and has presented this work internationally. Previously, Steven managed PharmaVentures’ Strategic Intelligence division, with responsibility for the development and production of PharmaDeals®. Steven has a BSc (Hons) in Biochemistry from the University of Dundee and a PhD in Genetics from University College London.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK